Life Scientist > Biotechnology

Genentech rejects Roche bid

15 August, 2008 by Kate McDonald

US biotech Genentech rejects $43.7 billion takeover deal


Acrux-Organon partnership dropped

15 August, 2008 by Dylan Bushell-Embling

Schering-Plough cancels two projects with Acrux


Life's Full Court appeal accepted

15 August, 2008 by Dylan Bushell-Embling

Life's legal battle with Bell IXL will continue, after the Full Court ordered a retrial.


Acrux heads to the Finnish

14 August, 2008 by Dylan Bushell-Embling

Acrux signs exclusive manufacturing partner for Testosterone MD-Lotion


Circadian owns Vegenics

14 August, 2008 by Dylan Bushell-Embling

Circadian finalises Vegenics purchase


Biotron expands HCV trial

14 August, 2008 by Dylan Bushell-Embling

Biotron adds Brisbane site for hep C clinical trial


Next trial for Starpharma

13 August, 2008 by Staff Writers

Starpharma studies VivaGel duration


Bioprocessing conference

13 August, 2008 by External Press Release Author

Australia's BioProcessing Network conference being held in October


CSL profit up 30pc, to outlay $3.5b for Talecris

13 August, 2008 by Kate McDonald

CSL reports massive earnings, agrees to buy US plasma business Talecris


Clean air for Pharmaxis

13 August, 2008 by Dylan Bushell-Embling

Pharmaxis concludes dose study of Bronchitol in cystic fibrosis patients


Another win for CogState

12 August, 2008 by Dylan Bushell-Embling

CogState wins $1.2 million technology contract


Acrux simplifies KV deal

12 August, 2008 by Dylan Bushell-Embling

Acrux expands partnership agreement with KV Pharmaceuticals


Cochlear profit up

12 August, 2008 by Dylan Bushell-Embling

Cochlear records 15% profit growth


Knees next for Mesoblast

12 August, 2008 by Dylan Bushell-Embling

Mesoblast's stem cells able to regenerate damaged knee cartilage


Growth for Tissue Therapies

11 August, 2008 by Kate McDonald

Tissue Therapies begins first trial in patient with venous ulcer


  • All content Copyright © 2025 Westwick-Farrow Pty Ltd